Shefali V Patel, DMD | |
1035 W Ramsey St, Suite B-2, Banning, CA 92220-4400 | |
(714) 322-5021 | |
(714) 398-8026 |
Full Name | Shefali V Patel |
---|---|
Gender | Female |
Speciality | Dentist - General Practice |
Location | 1035 W Ramsey St, Banning, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932394806 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 56240 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shefali V Patel, DMD 1240 Border Ave, Suite B-2, Corona, CA 92882-3801 Ph: (951) 595-8007 | Shefali V Patel, DMD 1035 W Ramsey St, Suite B-2, Banning, CA 92220-4400 Ph: (714) 322-5021 |
News Archive
Her diagnosis was scary: Alzheimer's Disease. So Myriam Torres was desperate for accurate information and help with coping with what the future might bring.
Type 2 diabetes - the most common type of diabetes - triples the risk of an early menopause in women younger than 45 years of age, according to new research published in the peer-reviewed journal Climacteric.
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.
Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.
› Verified 6 days ago
Dr. James Richard Lloyd, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 300 S Highland Springs Ave, Suite 2l, Banning, CA 92220 Phone: 951-769-7158 Fax: 951-769-7160 | |
John Choe, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 617 W Ramsey, Banning, CA 92220 Phone: 951-849-4649 Fax: 951-849-2386 | |
Dr. Christopher Brent Peeke, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 264 N Highland Springs Ave, Suite 5b, Banning, CA 92220 Phone: 951-845-4685 | |
Dr. Stanley Kelly Miller, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 6350 W Ramsey St, #a, Banning, CA 92220 Phone: 951-769-0466 Fax: 951-769-3606 | |
Dr. Sungjo J Choi, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 300 S Highland Springs Ave Ste 2l, Banning, CA 92220 Phone: 951-769-7158 Fax: 951-769-7160 | |
Ms. Jale Berhanu, DDS. Dentist Medicare: Not Enrolled in Medicare Practice Location: 471 N San Gorgonio Ave, Banning, CA 92220 Phone: 951-849-2888 Fax: 951-849-2140 | |
Mr. Dale Kirkendall, DDS. Dentist Medicare: Not Enrolled in Medicare Practice Location: 471 N San Gorgonio Ave, Banning, CA 92220 Phone: 951-849-2888 Fax: 951-849-1454 |